?? Omics-Insights: Your Weekly Genomics & Proteomics Digest ??

Welcome to our latest Omics newsletter, your portal for the freshest updates and innovations in genomics. This week's newsletter brings you the latest updates from the dynamic world of Omics. In this edition, we bring you the latest developments in the dynamic world of Omics, including key industry news, strategic collaborations, skill development essentials for finding a new job, & essential career tips for omics professionals.

This week's latest news in the field of Life Science:

PacBio Teams Up for Fertility Research Across Asia ??

Pacific Biosciences has partnered with five healthcare centers in Asia to form the HiFi Solves Sub-fertility Consortium. Led by Singapore’s KK Women’s and Children’s Hospital, and including institutions from Thailand, Taiwan, and South Korea, the group will use PacBio’s HiFi long-read sequencing to advance the diagnosis and treatment of subfertility and recurrent miscarriages. This collaboration is part of a broader initiative by PacBio, aimed at refining clinical research practices using their Revio sequencer. #fertilityresearch #genomics #pacbio #sequencing #hifisolves #longreadsequencing #asiaconsortium #reproductivemedicine #subfertility #precisionmedicine #miscarriageresearch #clinicalresearch #biotechnology #hospitallabs #genomictechnology #NGS #healthcarepartnerships #lifesciences #biotechnews #innovation #federateddata

Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Testing in Europe ??

Pillar Biosciences and AstraZeneca have joined forces to bring next-generation sequencing (NGS) liquid biopsy testing to Europe. Using Pillar's OncoReveal LBx kits, this collaboration aims to quickly detect tumors with actionable genomic alterations. The partnership hopes to expand patient access to targeted therapies, offering rapid and simplified NGS workflows to a broader range of labs. #liquidbiopsy #NGS #pillarbiosciences #astrazeneca #oncology #genomicsequencing #cancertreatment #precisionmedicine #biotechpartnerships #oncologytesting #researchuseonly #tumorprofiling #cancerresearch #biotechnology #healthcareequity #diagnostictesting #molecularoncology #nextgensequencing #genomicalterations #cancerdetection

Oxford Nanopore Files Lawsuit Against BGI Over Contract Breach ??

Oxford Nanopore Technologies is preparing to sue BGI Group affiliates in England, alleging contract breaches and misuse of trade secrets. This legal battle targets BGI’s CycloneSeq nanopore sequencing technology, which Oxford Nanopore claims infringes on their proprietary rights. BGI recently launched CycloneSeq-based sequencers, but the pending lawsuit could hinder their entry into Western markets. #oxfordnanopore #BGI #nanoporesequencing #lawsuit #biotechlawsuits #contractbreach #tradingsecrets #sequencingtech #biotechnology #genomics #westernmarkets #cycloneseq #patentinfringement #biosecureact #DNAsequencing #biotechlegal #innovationprotection #techlawsuit #genomicrights #patentlaws #legalaction

LuminUltra Acquires Genomadix’s Legionella Testing Business ??

LuminUltra has acquired the Legionella testing business from Genomadix, including the Cube portable molecular testing system, which delivers rapid RT-qPCR results. This move strengthens LuminUltra's ability to monitor and manage Legionella bacteria, often found in building water systems. Genomadix will focus on commercializing precision medicine tests on the Cube platform. #luminultra #genomadix #legionella #waterquality #moleculartesting #rapidtesting #publichealth #legionelladisease #environmentaltesting #cubeplatform #biotechnology #diagnostics #precisionmedicine #healthcareinnovation #rtqpcr #infectioncontrol #bacteriamonitoring #watermanagement #portabletesting #infieldtesting

Agena Bioscience Expands into South America ??

Agena Bioscience has entered South American markets through distribution agreements with EXSA SRL in Argentina and Uniscience do Brasil in Brazil. These partnerships will expand the reach of Agena’s MassArray system, enabling advanced genomic research, including somatic genotyping and methylation profiling. The company is focused on growing its presence in the molecular diagnostics field. #agenabioscience #genomicresearch #massarray #southamerica #molecularresearch #distributiondeals #argenitna #brazil #EXSA #uniscience #genotyping #methylationprofiling #biotechnology #genomics #moleculardiagnostics #labproducts #biotechnews #marketexpansion #researchproducts #scientificinnovation #genomictools

?? My Opinion on This Week's News:

The collaboration between Pacific Biosciences and Asian healthcare centers highlights the increasing importance of genomics in tackling reproductive health issues like subfertility. This type of research could offer profound improvements in diagnostics and treatments, signaling how cutting-edge sequencing technologies can drive impactful change in fertility medicine. Meanwhile, the partnership between Pillar Biosciences and AstraZeneca to expand liquid biopsy testing across Europe is another example of how genomics is transforming cancer diagnostics, offering patients more accessible and accurate ways to identify actionable genomic mutations.

The brewing legal battle between Oxford Nanopore and BGI is significant because it reflects the rising tensions in the biotech industry over proprietary technology and patents, especially in a competitive space like sequencing. This lawsuit could shape how companies protect their intellectual property in the global market. LuminUltra’s acquisition of Genomadix’s Legionella testing business points to the growing need for rapid and portable diagnostic solutions, not only in healthcare but also in environmental monitoring—this move will likely elevate LuminUltra’s market presence. Finally, Agena Bioscience's expansion into South America through key distribution partnerships is a strategic step forward, particularly as molecular diagnostics continues to spread across emerging markets. This positions Agena to play a larger role in driving genomic research in regions with untapped potential.

Current Live Roles at Kinetica:

Field Service Engineer - Imaging Equipment - Benelux

Senior Account Manager - Proteomics - Boston

Director of Product Management - Imaging Equipment - Benelux

Director of Customer Success and Support - Genomics - West Coast

Account Manager - Proteomics - Belgium

Account Manager - Genomics - California

Scientist - Maryland - Antibodies

Director of Manufacturing - Maryland - Life Science

Job Hunting Tips from an Omics Specialist Recruiter: When to Discuss Salary ??

One of the most common questions job seekers have is, "When is the right time to talk about salary during an interview?" As a recruiter in the genomics and omics space, I recommend waiting until the final stages of the interview process to bring up compensation. Your initial focus should be on demonstrating your value—how your skills and experience align with the company's needs.

Typically, salary discussions happen naturally after you’ve had a chance to showcase your expertise and the employer is convinced you’re a strong fit. If the employer brings up salary early, you can briefly outline your expectations but avoid diving too deeply into specifics. When you get to the offer stage, that’s your opportunity to negotiate and ensure the compensation aligns with the market rates for your role and your personal expectations.

Timing is everything, be strategic!

Wrapping Up Another Omics-Insights:

Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as the science itself!